MDNAF
Price
$0.65
Change
+$0.01 (+1.56%)
Updated
Jul 3 closing price
Capitalization
51.58M
33 days until earnings call
MRVI
Price
$2.67
Change
+$0.02 (+0.75%)
Updated
Jul 3 closing price
Capitalization
384.41M
37 days until earnings call
Interact to see
Advertisement

MDNAF vs MRVI

Header iconMDNAF vs MRVI Comparison
Open Charts MDNAF vs MRVIBanner chart's image
Medicenna Therapeutics
Price$0.65
Change+$0.01 (+1.56%)
Volume$1.04K
Capitalization51.58M
Maravai LifeSciences Holdings
Price$2.67
Change+$0.02 (+0.75%)
Volume$878.19K
Capitalization384.41M
MDNAF vs MRVI Comparison Chart in %
Loading...
MDNAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MDNAF vs. MRVI commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDNAF is a Hold and MRVI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (MDNAF: $0.64 vs. MRVI: $2.67)
Brand notoriety: MDNAF and MRVI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MDNAF: 1% vs. MRVI: 49%
Market capitalization -- MDNAF: $51.58M vs. MRVI: $384.41M
MDNAF [@Biotechnology] is valued at $51.58M. MRVI’s [@Biotechnology] market capitalization is $384.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDNAF’s FA Score shows that 0 FA rating(s) are green whileMRVI’s FA Score has 1 green FA rating(s).

  • MDNAF’s FA Score: 0 green, 5 red.
  • MRVI’s FA Score: 1 green, 4 red.
According to our system of comparison, MRVI is a better buy in the long-term than MDNAF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDNAF’s TA Score shows that 5 TA indicator(s) are bullish while MRVI’s TA Score has 5 bullish TA indicator(s).

  • MDNAF’s TA Score: 5 bullish, 5 bearish.
  • MRVI’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MRVI is a better buy in the short-term than MDNAF.

Price Growth

MDNAF (@Biotechnology) experienced а -3.42% price change this week, while MRVI (@Biotechnology) price change was +12.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

MDNAF is expected to report earnings on Aug 08, 2025.

MRVI is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRVI($384M) has a higher market cap than MDNAF($51.6M). MDNAF YTD gains are higher at: -44.330 vs. MRVI (-51.009). MDNAF has higher annual earnings (EBITDA): -18.65M vs. MRVI (-190.13M). MRVI has more cash in the bank: 285M vs. MDNAF (30M). MDNAF has less debt than MRVI: MDNAF (174K) vs MRVI (371M). MRVI has higher revenues than MDNAF: MRVI (242M) vs MDNAF (0).
MDNAFMRVIMDNAF / MRVI
Capitalization51.6M384M13%
EBITDA-18.65M-190.13M10%
Gain YTD-44.330-51.00987%
P/E RatioN/AN/A-
Revenue0242M-
Total Cash30M285M11%
Total Debt174K371M0%
FUNDAMENTALS RATINGS
MDNAF: Fundamental Ratings
MDNAF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
86
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MDNAFMRVI
RSI
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
85%
Momentum
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
82%
MACD
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
77%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
Bearish Trend 19 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
88%
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
MDNAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MKTAY31.900.34
+1.06%
Makita Corp.
EUSP0.04N/A
N/A
Eurosite Power Inc.
HLFFF10.31N/A
N/A
Hellofresh SE
NPPXF0.93-0.02
-2.32%
NTT Inc
FKYS18.75-0.49
-2.55%
First Keystone Corp.

MDNAF and

Correlation & Price change

A.I.dvisor tells us that MDNAF and DTIL have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MDNAF and DTIL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDNAF
1D Price
Change %
MDNAF100%
-0.71%
DTIL - MDNAF
27%
Poorly correlated
+1.88%
HRTX - MDNAF
26%
Poorly correlated
+2.33%
ARWR - MDNAF
25%
Poorly correlated
-0.65%
CRBU - MDNAF
23%
Poorly correlated
N/A
MRVI - MDNAF
22%
Poorly correlated
+0.75%
More

MRVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRVI has been loosely correlated with CRDF. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MRVI jumps, then CRDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRVI
1D Price
Change %
MRVI100%
+0.75%
CRDF - MRVI
41%
Loosely correlated
+1.95%
TECH - MRVI
38%
Loosely correlated
-0.08%
IGMS - MRVI
34%
Loosely correlated
+3.03%
NRIX - MRVI
32%
Poorly correlated
+2.33%
NAUT - MRVI
32%
Poorly correlated
+4.73%
More